Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    18502299 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Human Insulin (Novolin-R, Novo Nordisk);   Device: H-Tron Plus V100; Disetronic Medical System, Burgdorf, Switzerland;   Other: Pre-meal;   Drug: Novolin-R;   Drug: Human Insulin NPH (Novolin-N, Novo Nordisk);   Drug: Gliclazide (Diamicron, Servier);   Drug: Diamicron and Glucophage
2 Completed INSPIRE Diabetes Study: Basal Bolus Insulin as Primary Treatment of Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Intensive insulin;   Drug: Routine Care

Indicates status has not been verified in more than two years